Loading, Please Wait...
NEW YORK, June 12, 2019 (GLOBE NEWSWIRE) -- Halper Sadeh LLP, a global investor rights law firm, is investigating whether the sale of Medidata Solutions, Inc. (“Medidata” or the “Company”) (NASDAQ: MDSO) to Dassault Systèmes (“Dassault”) is fair to Medidata shareholders. On behalf of Medidata shareholders, Halper Sadeh LLP may seek increased consideration for shareholders, additional disclosures and information concerning the proposed transaction, or other relief and benefits.
If you are a Medidata shareholder and would like to discuss your legal rights and options, please visit Medidata Merger or contact Daniel Sadeh or Zachary Halper at (212) 763-0060 or firstname.lastname@example.org or email@example.com.
On April 30, 2019, Piper Jaffray Companies set a target price for Medidata at $96.00 per share. The Medidata merger investigation concerns whether Medidata and its Board of Directors violated the federal securities laws and/or their fiduciary duties to shareholders by failing to: (1) obtain the best possible price for Medidata shareholders; (2) determine whether Dassault is underpaying for Medidata; and (3) disclose all material information necessary for Medidata shareholders to adequately assess and value the merger consideration.
If you are a Medidata shareholder and would like to discuss your legal rights and options, please visit https://halpersadeh.com/actions/medidata-solutions-inc-mdso-merger-stock-dassault/ or contact Daniel Sadeh or Zachary Halper at (212) 763-0060 or firstname.lastname@example.org or email@example.com.
Halper Sadeh LLP represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.
Attorney Advertising. Prior results do not guarantee or predict a similar outcome with respect to any future matter.